• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Aescap Venture

edit

Aescap Venture is a venture capital company investing in private medical companies in Europe.

Aescap invests in high-potential companies with realistic product opportunities and the potential to generate cashflow from licensing deals. This involves investments in all phases of development with an emphasis on earlier stages.

Aescap Venture’s added value is based on a multi-disciplinary team of experienced investment partners. Each has a proven track record of success and the skills to coach entrepreneurs in accelerating the growth of their companies.

Aescap is an acronym for ”Accelerating European Science Companies and Products” and derived from Aesculapius - the Greek god of healthcare - and capital.

Recent Milestones

edit

• 
  Aescap Venture invested in Orphazyme. (9/7/11)
  Posted 9/7/11 at 6:46pm via fiercebiotech.com
• 
  Aescap Venture invested in Avantium Technologies. (6/9/11)
  Posted 6/9/11 at 6:58pm via techcrunch.com
• 
  Aescap Venture invested in f-star Biotech. (4/13/11)
  Posted 7/17/11 at 6:02pm via f-star.com
• 
  Aescap Venture invested in i-Optics. (11/1/10)
  Posted 11/1/10 at 6:40pm via finsmes.com
• 
  Aescap Venture invested in Biocartis. (4/8/10)
  Posted 7/8/10 at 8:39pm via biocartis.com
• 
  Aescap Venture invested in Aquapharm Biodiscovery . (4/5/10)
  Posted 4/5/10 at 10:58am via stanford.edu
• 
  Aescap Venture invested in Avantium Technologies. (10/29/08)
  Posted 6/17/09 at 10:04pm via equityhelpdesk.com
• 
  Aescap Venture invested in Vivendy Therapeutics. (1/1/08)
  Posted 6/19/09 at 5:30am
• 
  Aescap Venture invested in f-star Biotech. (9/10/07)
  Posted 3/13/10 at 4:57am via f-star.com
• 
  Aescap Venture invested in Aquapharm Biodiscovery . (7/26/07)
  Posted 3/15/10 at 7:57pm via talentscotland.com
• 
  Aescap Venture invested in ProtAffin Biotechnologie. (5/4/07)
  Posted 3/16/10 at 3:29am via protaffin.com

Investments

Videos

Sources

1. Orphazyme lands $20M A round to back new drugs for rare genetic disorder (fiercebiotech.com) [edit]
2. Shell Spinoff Avantium Raises $43.9 Million To Develop Green Plastics, Chemicals And Fuel (techcrunch.com) [edit]
3. f-star raises €15M in a New Financing led by SR One (f-star.com) [edit]
4. i-Optics Closes €4.2M Third Financing Round (finsmes.com) [edit]
5. Biocartis raises €30 million in Series ‘B' financing round (biocartis.com) [edit]
6. Aquapharm Biodiscovery, Ltd.: Series C $6.4M (coursework.stanford.edu) [edit]
7. Avantium Raises €18 Million (equityhelpdesk.com) [edit]
8. Capital Funding Report [edit]
9. Antibody Engineering Company F-Star Raises EUR 6.0 million in Series A Financing from Aescap Venture and Atlas Venture (f-star.com) [edit]
10. Aquapharm Secures Second Round Investment of £4M (talentscotland.com) [edit]
11. ProtAffin AG secures Series A financing (2a.protaffin.com) [edit]